Trihexyphenidyl Withdrawal Encephalopathy
Ann Neurol 41:133-134, Johkura,K.,et al, 1997
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Botulinum Toxin Versus Trihexphenidyl in Cervical Dystonia:A Prospective, Randomized, Double-Blind Controlled Study
Neurol 46:1066-1072, Brans,J.W.M.,et al, 1996
The Dystonias
BMJ 300:139-144, Marsden,C.D.&Quinn,N.P., 1990
Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990
Life-Threatening Cranial Dystonia Following Trihexyphenidyl Withdrawal
Movement Disorders 4:349-353, Gimenez-Roldan,S.,et al, 1989
Parkinson's Disease & Myasthenia Gravis:Adverse Effect of Trihexyphenidyl on Neuromuscular Transmission
Neurol 37:832-833, Ueno,S.,et al, 1987
Torsion Dystonia:A Double-Blind, Prospective Trial of High-Dosage Trihexyphenidyl
Neurol 36:160-164, Burke,R.E.,et al, 1986
High Dosage Anticholinergic Therapy in Dystonia
Neurol, 33:1255-12611983., Fahn,S., 1983